# Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)

> **NCT07206849** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Nationwide Children's Hospital** · enrollment: 79 (estimated)

## Conditions studied

- High Grade Glioma (HGG) of the Brain With BRAF Aberration
- High Grade Glioma (III or IV)
- Diffuse Intrinsic Pontine Glioma
- High Grade Glioma
- WHO Grade 3 Glioma
- WHO Grade 4 Glioma
- Metastatic Brain Tumor

## Interventions

- **DRUG:** Tovorafenib

## Key facts

- **NCT ID:** NCT07206849
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2030-05
- **Final completion:** 2037-05
- **Target enrollment:** 79 (ESTIMATED)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07206849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07206849, "Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07206849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*